Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Capillary and Venous Blood Sampling Devices Market size was valued at USD 1.8 billion in 2024 and is projected to reach a valuation of USD 4.5 billion by the end of 2037, rising at a CAGR of 7% during the forecast period, i.e., 2025-2037. In 2025, the industry size of capillary and venous blood sampling devices is estimated at USD 2 billion.
The global capillary and venous blood sampling devices market is on an upward trend attributed to the development of micro blood sampling techniques and the use of point-of-care diagnostics. The rise in the number of diabetes, cardiovascular diseases, and overall chronic diseases has created the need for effective, non-invasive, and home-use blood sampling. In April 2024, the NanoDrop lancet device was granted over-the-counter status by the FDA, allowing patients to obtain capillary blood samples at home for HbA1c testing. This underlines the ongoing transition towards increased patient autonomy and a focus on home-based treatment.
Governments across the globe are pushing for better blood collection techniques and POC testing to enhance the delivery of healthcare services. As per the CDC (Centers for Disease Control and Prevention) data, there are 125.7 million outpatient department visits in the U.S. every year, emphasizing the need for blood testing and diagnostic services. Governments are investing in research and development to improve the sampling methods and minimize the use of venipuncture-based tests, which are beneficial to the patients.
